Target intelligence / Profile preview

Dynamin 1 pseudogene 46 (DNM1P46)

Target
DNM1P46
Molecular classification
Other (Pseudogene)
01

Overview

Dynamin 1 pseudogene 46 (DNM1P46) is a processed pseudogene related to the dynamin 1 gene (DNM1), which encodes a mechanochemical GTPase essential for clathrin-mediated endocytosis and synaptic vesicle recycling[1][3][5]. However, DNM1P46 itself does not encode a functional protein; as a pseudogene, it is not involved in protein synthesis or recognized biological pathways, nor is it a therapeutic target, disease gene, or biomarker. The canonical full-length gene, DNM1, plays important roles in neuronal function and is linked to epilepsy and other neurodevelopmental disorders[1][5]; these disease associations do not apply to DNM1P46. There are no known drugs, mechanisms of action, or safety concerns associated with DNM1P46. Additional context: - Pseudogenes are genetic elements that resemble protein-coding genes but are typically non-functional due to mutations or lack of regulatory elements. - The association of the "Putative GED domain-containing protein" in aliases reflects sequence homology only; DNM1P46 does not produce a functional GED domain-containing protein. - If you are seeking information about the functional dynamin 1 gene or protein, that is a GTPase involved in vesicle scission during endocytosis, but this does not apply to DNM1P46[1][3][5].

Other names
Putative GED domain-containing protein DNM1P46C15orf51DNM1DN14.2FLJ45937DKFZp434I1020DNM1 pseudogene 46

Beyond the preview

Go deeper on Dynamin 1 pseudogene 46 (DNM1P46).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dynamin 1 pseudogene 46 (DNM1P46).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call